Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Rheumatoid Arthritis
Interventions
DRUG

fostamatinib

fostamatinib 100 mg twice daily

DRUG

placebo

placebo

Trial Locations (56)

Unknown

Research Site, Huntsville

Research Site, Huntington Beach

Research Site, Santa Maria

Research Site, Trumbull

Research Site, Boca Raton

Research Site, Brandon

Research Site, Orlando

Research Site, Tampa

Research Site, Venice

Research Site, Decatur

Research Site, South Bend

Research Site, Cumberland

Research Site, Frederick

Research Site, Hagerstown

Research Site, Florissant

Research Site, Richmond Heights

Research Site, Freehold

Research Site, Albuquerque

Research Site, Brooklyn

Research Site, Charlotte

Research Site, Greensboro

Research Site, Lake Oswego

Research Site, Duncansville

Research Site, Memphis

Research Site, Austin

Research Site, Dallas

Research Site, Houston

Research Site, Lubbock

Research Site, Nassau Bay

Research Site, Tacoma

Research Site, Sevlievo

Research Site, Sofia

Research Site, Brno

Research Site, Hlučín

Research Site, Hostivice

Research Site, Kladno

Research Site, Ostrava-Trebovice

Research Site, Prague

Research Site, Aachen

Research Site, Halle

Research Site, Gdynia

Research Site, Grodzisk Mazowiecki

Research Site, Kalisz

Research Site, Katowice

Research Site, Lodz

Research Site, Poznan

Research Site, Środa Wielkopolska

Research Site, Wroclaw

Research Site, Bloemfontein

Research Site, Cape Town

Research Site, Durban

Research Site, Kempron Park

Research Site, Donetsk

Research Site, Kyiv

Research Site, Vinnytsia

Research Site, Zaporizhzhya

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY